LINCOLN PHARMA LTD
Long

keep an eye #PotentialBreakout

Debt to equity : 0.00
Profit Growth 10 Years: 33%
CAGR 10 Years: 25%

Promoter holding has increased by 3.85% over last quarter.

Promoters increasing their stake is a sign of high confidence in the future of the business

Wyłączenie odpowiedzialności